CKD-828, D097, D337

DRUG8 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

DyslipidemiasHypertensionHypertension and Dyslipidemia

Phase 1

A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348

CompletedNCT04258865

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2020-03-25End: 2020-05-13Updated: 2020-06-05

A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348

CompletedNCT04587206

Chong Kun Dang PharmaceuticalHypertension and Dyslipidemia

Start: 2020-10-15End: 2021-01-15Updated: 2021-02-04

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348

CompletedNCT04660370

Chong Kun Dang PharmaceuticalHypertension and Dyslipidemia

Start: 2021-01-09End: 2021-04-15Updated: 2024-01-23

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)

CompletedNCT04883658

Chong Kun Dang PharmaceuticalHypertension and Dyslipidemia

Start: 2021-06-04End: 2021-08-19Updated: 2024-01-23

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

CompletedNCT05192356

Chong Kun Dang PharmaceuticalHypertension and Dyslipidemia

Start: 2022-02-23End: 2022-06-08Updated: 2023-06-09

Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348

CompletedNCT05549401

Chong Kun Dang PharmaceuticalHypertension and Dyslipidemia

Start: 2022-09-29End: 2022-12-09Updated: 2023-06-09

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)

CompletedNCT05749861

Chong Kun Dang PharmaceuticalHypertension and Dyslipidemia

Start: 2023-04-22End: 2023-07-18Updated: 2024-01-23

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)

CompletedNCT06112678

Chong Kun Dang PharmaceuticalDyslipidemias, Hypertension

Start: 2024-01-04End: 2024-03-18Updated: 2024-03-26